All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Average Weight Loss On Mounjaro: By Month

See the average weight loss on Mounjaro broken down by month. Understand the dose titration timeline, what each month looks like, and how to optimize...

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

See the average weight loss on Mounjaro broken down by month. Understand the dose titration timeline, what each month looks like, and how to improve your monthly progress.

Mounjaro (tirzepatide) delivers some of the fastest and most substantial monthly weight loss of any GLP-1 medication, with patients losing an average of 4 to 6 pounds per month during the first 6 months and continuing to lose weight through at least 18 months of treatment. Here is exactly what the data shows for each month.

Mounjaro's dual GIP/GLP-1 receptor mechanism produces consistently higher monthly weight loss rates compared to single-receptor GLP-1 medications. Understanding the month-by-month trajectory helps you evaluate your own progress and work with your provider to improve results. how Mounjaro works

Month-by-Month Weight Loss Data

The following table synthesizes data from the SURMOUNT-1 trial[1] (patients with obesity, no diabetes) across all three dose levels. Starting weight in the trial was approximately 231 pounds on average.

Average Monthly Weight Loss on Mounjaro by Dose
Month Dose Range Cumulative Loss (5 mg) Cumulative Loss (10 mg) Cumulative Loss (15 mg)
1 2.5 mg 3 to 4 lbs 3 to 5 lbs 4 to 6 lbs
2 5 mg 8 to 10 lbs 9 to 11 lbs 10 to 13 lbs
3 5 to 7.5 mg 13 to 15 lbs 15 to 18 lbs 17 to 20 lbs
4 7.5 to 10 mg 16 to 19 lbs 20 to 24 lbs 23 to 27 lbs
6 10 to 15 mg 22 to 25 lbs 28 to 33 lbs 33 to 38 lbs
9 Maintenance 27 to 30 lbs 36 to 40 lbs 40 to 44 lbs
12 Maintenance 30 to 33 lbs 40 to 43 lbs 44 to 47 lbs
18 (end SURMOUNT-1) Maintenance ~35 lbs ~45 lbs ~48 lbs

What Each Month Looks Like in Practice

Month 1: Getting Started (2.5 mg)

The 2.5 mg introductory dose lets your body adjust to tirzepatide's effects. Even at this low dose, most patients experience a noticeable shift in appetite. Meals become more manageable, and between-meal hunger decreases. Weight loss during this first month typically ranges from 3 to 6 pounds. Check out our see real Zepbound results for detailed data.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Average Weight Loss On Mounjaro: By Month

Side effects are generally mild. The most common are nausea (affecting about 15% to 20% of patients), decreased appetite, and occasional diarrhea or constipation. These symptoms usually peak during the first week and improve as your body adapts. Mounjaro first month tips

Month 2: Noticeable Appetite Changes (5 mg)

The step up to 5 mg brings stronger appetite suppression. Many patients say this is the month where they truly feel the medication working. Portions shrink naturally, and the urge to snack or eat out of boredom diminishes. Cumulative weight loss reaches roughly 4% to 5% of starting weight.

This is also when patients begin to notice subtle changes in how their clothes fit. The scale may show 8 to 13 pounds lost, depending on the target dose. Blood sugar levels often start improving during this month, particularly for patients with insulin resistance or prediabetes.

Month 3: Visible Progress (7.5 mg)

By month 3, many patients have lost enough weight for the changes to become visible. Faces appear slimmer, waistlines shrink, and rings and watches may feel looser. Cumulative weight loss often reaches 7% to 9% of starting weight on the higher dose tracks.

Energy and mobility improvements are common during this month. Patients who were previously limited in their physical activity often find they can walk farther, climb stairs more easily, and exercise with less discomfort. This creates a positive feedback loop that supports ongoing weight loss. exercise on Mounjaro

Months 4 to 6: Peak Rate Phase (10 to 15 mg)

This period typically produces the fastest monthly weight loss rates. Patients are reaching or have reached their target maintenance dose, and the dual GIP/GLP-1 mechanism is operating at full strength. Monthly losses of 3 to 5 pounds are common during this stretch.

By month 6, cumulative weight loss often reaches 14% to 17% of starting weight on the 15 mg dose. To put that in practical terms, a patient who started at 250 pounds is now around 210 to 215 pounds. That's a substantial visible transformation.

Health markers frequently improve dramatically during this phase. Blood pressure, triglycerides, HbA1c, liver enzymes, and inflammatory markers often show significant positive changes. Many patients are able to reduce or eliminate other medications under their provider's guidance. Mounjaro metabolic improvements

Months 7 to 12: Continued Progress

The rate of monthly weight loss gradually decreases during this period, but weight continues to come off. Monthly losses of 1 to 3 pounds are typical. This deceleration is biologically normal as the body adjusts to a lower weight and the caloric deficit narrows.

By month 12, patients on the 15 mg dose have typically lost 19% to 21% of their starting weight. The 10 mg dose group reaches approximately 17% to 19%, and the 5 mg group reaches approximately 13% to 15%. All three dose levels produce clinically meaningful results.

Months 13 to 18: Extended Results

The SURMOUNT-1 trial ran through 72 weeks (approximately 18 months), and weight loss continued throughout. The final 6 months of the trial added approximately 1% to 2% more weight loss for most patients. While the monthly rate is modest during this phase, the fact that weight continues trending downward rather than rebounding is significant.

How Mounjaro Monthly Weight Loss Compares

Monthly Weight Loss Rate Comparison (Approximate)
Medication Avg Monthly Loss (Months 2-6) Avg Monthly Loss (Months 7-12) Total at 12 Months
Mounjaro 15 mg 4 to 6 lbs 1 to 3 lbs 44 to 47 lbs
Wegovy 2.4 mg 3 to 5 lbs 1 to 2 lbs 33 to 35 lbs
Ozempic 1.0 mg 2 to 4 lbs 1 to 2 lbs 20 to 28 lbs

Mounjaro vs Wegovy vs Ozempic

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Maximizing Each Month

Protein at every meal. As your total caloric intake drops, making sure protein makes up a larger share of your diet helps preserve muscle mass and keeps you feeling satisfied between meals. Aim for 80 to 120 grams daily. nutrition guide for Mounjaro patients

Stay hydrated. Dehydration is one of the most under-recognized issues for patients on GLP-1 medications. When you eat less, you also consume less water from food. Aim for at least 64 to 80 ounces of fluids daily.

Build exercise gradually. Start where you're comfortable and add intensity over time. Walking is an excellent foundation. As your weight decreases and your energy improves, consider adding swimming, cycling, or resistance training to further enhance your results.

Manage expectations during plateaus. Nearly every patient experiences at least one plateau during their Mounjaro treatment. A plateau lasting 2 to 4 weeks is normal. If it extends beyond 6 weeks, work with your provider to explore potential adjustments.

Frequently Asked Questions

How much weight will I lose in the first 3 months on Mounjaro?

Most patients lose 7% to 9% of their body weight in the first 3 months, which translates to approximately 15 to 20 pounds for someone starting at 230 pounds. Patients on the higher dose tracks tend to lose slightly more during this period.

Does weight loss slow down after month 6 on Mounjaro?

The rate of loss does decrease after month 6, which is a normal physiological response. But weight continues to decrease through at least 18 months of treatment. Think of it as a gradual transition from active weight loss to weight stabilization at a much lower level.

Is losing 5 pounds per month on Mounjaro a good result?

Five pounds per month is an excellent rate of weight loss that's sustainable and healthy. Over 12 months, that pace would total 60 pounds, which exceeds the clinical trial average. Not every month will produce exactly 5 pounds, but averaging near that rate indicates strong response to treatment.

Why did I lose more weight in month 2 than month 5?

This pattern is common and normal. Early weight loss includes some water weight and initial metabolic response, which can produce higher numbers in the first few months. As your body adjusts to a lower weight, the monthly rate naturally moderates. The overall trajectory is what matters most.

Medical References

  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]

Get Expert Monthly Monitoring with FormBlends

FormBlends provides physician-supervised Mounjaro and tirzepatide treatment with monthly progress reviews. Our telehealth platform lets you connect with your care team, review your monthly weight loss trajectory, and make data-driven adjustments to your treatment plan. get started with FormBlends

Start your consultation today and begin your Mounjaro process with clinical guidance every step of the way.

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Average Weight Loss On Mounjaro: By Month custom 2026 header image for GLP-1 Weight Loss
Custom header image for Average Weight Loss On Mounjaro: By Month, GLP-1 Weight Loss, and better treatment decision-making.

Research Snapshot

Medication guide
Page type
Medication guide
Page metadata
Page updated
2026-04-01
Page metadata
FormBlends official source
Official source
Mounjaro official website
Official source
Ozempic official website
Official source
Retatrutide official website
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-04-01.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

Average Weight Loss On Mounjaro: By Month research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.